Anders Molven

12.3k total citations · 1 hit paper
168 papers, 7.0k citations indexed

About

Anders Molven is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Anders Molven has authored 168 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Surgery, 80 papers in Molecular Biology and 60 papers in Genetics. Recurrent topics in Anders Molven's work include Pancreatic function and diabetes (80 papers), Diabetes and associated disorders (40 papers) and Metabolism, Diabetes, and Cancer (27 papers). Anders Molven is often cited by papers focused on Pancreatic function and diabetes (80 papers), Diabetes and associated disorders (40 papers) and Metabolism, Diabetes, and Cancer (27 papers). Anders Molven collaborates with scholars based in Norway, United States and United Kingdom. Anders Molven's co-authors include Pål R. Njølstad, Oddmund Sövik, Helge Ræder, Stefan Johansson, Heike Immervoll, Dag Hoem, Anders Fjose, Lise Bjørkhaug, Jørn V. Sagen and Ingfrid S. Haldorsen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Anders Molven

166 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer

2016 359 citations Dag Hoem, Anders Molven et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Molven Norway	46	3.2k	2.9k	2.5k	1.5k	1.5k	168	7.0k
Takuya Moriya Japan	52	3.1k 1.0×	1.3k 0.4×	2.1k 0.9×	2.7k 1.8×	935 0.6×	336	9.3k
Chieko Mineo United States	44	3.6k 1.1×	1.7k 0.6×	1.3k 0.5×	680 0.4×	1.3k 0.9×	106	7.7k
Robert K. Semple United Kingdom	41	4.0k 1.3×	1.5k 0.5×	1.6k 0.7×	397 0.3×	1.3k 0.9×	153	7.6k
Matthew D. Ringel United States	55	3.6k 1.2×	1.7k 0.6×	1.3k 0.5×	2.1k 1.4×	5.1k 3.5×	176	9.1k
Giuseppe Damante Italy	49	5.2k 1.6×	705 0.2×	1.2k 0.5×	1.6k 1.0×	2.0k 1.4×	288	8.7k
Giuseppe Viglietto Italy	48	5.4k 1.7×	841 0.3×	663 0.3×	2.3k 1.5×	981 0.7×	150	8.2k
Kennichi Kakudo Japan	49	2.3k 0.7×	2.1k 0.7×	1.2k 0.5×	2.1k 1.3×	3.9k 2.7×	284	7.8k
S. P. A. Toledo Brazil	44	2.4k 0.8×	1.0k 0.4×	852 0.3×	687 0.4×	1.7k 1.1×	159	6.7k
Andrew Plump United States	31	3.7k 1.2×	2.7k 0.9×	806 0.3×	611 0.4×	1.2k 0.8×	42	9.1k
Gilbert J. Cote United States	46	3.3k 1.1×	1.4k 0.5×	912 0.4×	1.5k 1.0×	2.9k 2.0×	141	7.3k

Countries citing papers authored by Anders Molven

Since Specialization

Citations

This map shows the geographic impact of Anders Molven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Molven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Molven more than expected).

Fields of papers citing papers by Anders Molven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Molven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Molven. The network helps show where Anders Molven may publish in the future.

Co-authorship network of co-authors of Anders Molven

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Molven. A scholar is included among the top collaborators of Anders Molven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Molven. Anders Molven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molnes, Janne, et al.. (2024). Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 110(2). 554–563. 3 indexed citations

Kahraman, Sevim, Ercument Dirice, Giorgio Basile, et al.. (2022). Abnormal exocrine–endocrine cell cross-talk promotes β-cell dysfunction and loss in MODY8. Nature Metabolism. 4(1). 76–89. 33 indexed citations

Cardelli, Maurizio, Remco van Doorn, Francesco Piacenza, et al.. (2020). Association of HERV-K and LINE-1 Hypomethylation with Reduced Disease-Free Survival in Melanoma Patients. Epigenomics. 12(19). 1689–1706. 13 indexed citations

Pedersen, Line, Stian Knappskog, Per Eystein Lønning, et al.. (2020). Golgi-Localized PAQR4 Mediates Antiapoptotic Ceramidase Activity in Breast Cancer. Cancer Research. 80(11). 2163–2174. 14 indexed citations

Helgeland, Øyvind, Marc Vaudel, Pétur Benedikt Júlíusson, et al.. (2019). Genome-wide association study reveals dynamic role of genetic variation in infant and early childhood growth. Nature Communications. 10(1). 4448–4448. 49 indexed citations

Johansson, Bente B., Karianne Fjeld, Aristotelis Antonopoulos, et al.. (2018). The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants. Journal of Biological Chemistry. 293(50). 19476–19491. 12 indexed citations

Rachakonda, P. Sivaramakrishna, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, et al.. (2018). Telomere length and survival in primary cutaneous melanoma patients. Scientific Reports. 8(1). 10947–10947. 18 indexed citations

Hoem, Dag, et al.. (2017). Hypoglycemia and decreased insulin requirement caused by malignant insulinoma in a type 1 diabetic patient: when the hoof beats are from a zebra, not a horse. Clinical Case Reports. 5(6). 761–768. 8 indexed citations

Johansson, Bente B., Karianne Fjeld, Erling Tjora, et al.. (2017). The role of the carboxyl ester lipase (CEL) gene in pancreatic disease. Pancreatology. 18(1). 12–19. 62 indexed citations

10.

Johansson, Bente B., Henrik Irgens, Janne Molnes, et al.. (2016). Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. Diabetologia. 60(4). 625–635. 92 indexed citations

11.

Qu, Yi, Anne M. Øyan, Runhui Liu, et al.. (2013). Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling. Cancer Research. 73(23). 7090–7100. 61 indexed citations

12.

Hertel, Jens Kristoffer, Stefan Johansson, Kristian Midthjell, et al.. (2013). Type 2 diabetes genes – Present status and data from Norwegian studies. Norsk Epidemiologi. 23(1). 6 indexed citations

13.

Johansson, Bente B., Janniche Torsvik, Lise Bjørkhaug, et al.. (2011). Diabetes and Pancreatic Exocrine Dysfunction Due to Mutations in the Carboxyl Ester Lipase Gene-Maturity Onset Diabetes of the Young (CEL-MODY). Journal of Biological Chemistry. 286(40). 34593–34605. 74 indexed citations

14.

Allen, Hana Lango, Stefan Johansson, Sian Ellard, et al.. (2009). Polygenic Risk Variants for Type 2 Diabetes Susceptibility Modify Age at Diagnosis in Monogenic HNF1A Diabetes. Diabetes. 59(1). 266–271. 34 indexed citations

15.

Njølstad, Pål R., Anders Molven, & Leif Groop. (2009). Diabetes genetics. A seventh sense for the successful sequel of 'come together'. "The genotypes and phenotypes of diabetes". Bergen, Norway. April 22-26, 2009. 2nd meeting of 'EASD Study Group on Genetics of Diabetes' and 44th annual meeting of the 'Scandinavian Society for the Study of Diabetes'.. PubMed. 10(4). 466–71. 1 indexed citations

16.

Schubbert, Suzanne, Gideon Bollag, Natalya Lyubynska, et al.. (2007). Biochemical and Functional Characterization of Germ Line KRAS Mutations. Molecular and Cellular Biology. 27(22). 7765–7770. 70 indexed citations

17.

Immervoll, Heike, et al.. (2006). Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(6). 788–796. 78 indexed citations

18.

Bjørkhaug, Lise, et al.. (2005). Functional Dissection of the HNF-1alpha Transcription Factor: A Study on Nuclear Localization and Transcriptional Activation. DNA and Cell Biology. 24(11). 661–669. 23 indexed citations

19.

Sagen, Jørn V., et al.. (2005). Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus. Diabetic Medicine. 22(8). 1012–1015. 13 indexed citations

20.

Molven, Anders, et al.. (1992). The zebrafish homeobox gene hox[zf-114]: primary structure, expression pattern and evolutionary aspects. The International Journal of Developmental Biology. 36(2). 229–237. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact